151 related articles for article (PubMed ID: 8399019)
1. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding.
Gleeson N; Devitt M; Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1993 Aug; 100(8):768-71. PubMed ID: 8399019
[TBL] [Abstract][Full Text] [Related]
2. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
Gleeson NC; Buggy F; Sheppard BL; Bonnar J
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):274-7. PubMed ID: 8122512
[TBL] [Abstract][Full Text] [Related]
3. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.
Gleeson NC
Am J Obstet Gynecol; 1994 Jul; 171(1):178-83. PubMed ID: 8030696
[TBL] [Abstract][Full Text] [Related]
4. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
Koh SC; Singh K
J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
[TBL] [Abstract][Full Text] [Related]
5. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
[TBL] [Abstract][Full Text] [Related]
6. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
Rutanen E; Hurskainen R; Finne P; Nokelainen K
Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
[TBL] [Abstract][Full Text] [Related]
7. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
9. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
10. Endometrial lysosomal enzyme activity in ovulatory dysfunctional uterine bleeding, IUCD users and post-partum women.
Wang IY; Fraser IS; Barsamian SP; Manconi F; Street DJ; Cornillie FJ; Russell P
Mol Hum Reprod; 2000 Mar; 6(3):258-63. PubMed ID: 10694274
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase activity in the endometrium of women with normal menstrual blood loss and women with proven ovulatory menorrhagia.
Bonney RC; Higham JM; Watson H; Beesley JS; Shaw RW; Franks S
Br J Obstet Gynaecol; 1991 Apr; 98(4):363-8. PubMed ID: 2031895
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
14. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
[TBL] [Abstract][Full Text] [Related]
15. Endometrial haemostasis and menstruation.
Davies J; Kadir RA
Rev Endocr Metab Disord; 2012 Dec; 13(4):289-99. PubMed ID: 23180227
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
[TBL] [Abstract][Full Text] [Related]
17. Cyclical variation in endometrial oestrogen and progesterone receptors in women with normal menstruation and dysfunctional uterine bleeding.
Gleeson N; Jordan M; Sheppard B; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1993 Mar; 48(3):207-14. PubMed ID: 8335139
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-intrauterine system effects on hemostasis and menstrual blood loss in women seeking contraception.
Koh SC; Singh K
J Obstet Gynaecol Res; 2010 Aug; 36(4):838-44. PubMed ID: 20666954
[TBL] [Abstract][Full Text] [Related]
19. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Zhang WJ; Wojta J; Binder BR
J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
